1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Middle East and Africa Typhoid Fever Vaccines Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Middle East and Africa Typhoid Fever Vaccines Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Incidence and Mortality of Typhoid Accelerate Demand for Typhoid Conjugate Vaccines
5.2 Market Opportunities
- 5.2.1 Combination Vaccines
5.3 Future Trends
- 5.3.1 Government Support for the Typhoid Immunization to Favor Market
5.4 Impact of Drivers and Restraints
6. Middle East and Africa Typhoid Fever Vaccines Market Regional Analysis
6.1 Middle East and Africa Typhoid Fever Vaccines Market Overview
6.2 Middle East and Africa Typhoid Fever Vaccines Market Revenue 2017-2027 (US$ Million)
6.3 Middle East and Africa Typhoid Fever Vaccines Market Forecast Analysis
7. Middle East and Africa Typhoid Fever Vaccines Market Analysis – by Vaccine Type
7.1 Live Attenuated Vaccine
- 7.1.1 Overview
- 7.1.2 Live Attenuated Vaccine: Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Capsular Polysaccharide Vaccines
- 7.2.1 Overview
- 7.2.2 Capsular Polysaccharide Vaccines: Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Conjugate Vaccine
- 7.3.1 Overview
- 7.3.2 Conjugate Vaccine: Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. Middle East and Africa Typhoid Fever Vaccines Market Analysis – by Route of administration
8.1 Oral and Injectable
- 8.1.1 Overview
- 8.1.2 Oral and Injectable: Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9. Middle East and Africa Typhoid Fever Vaccines Market – Middle East and Africa Analysis
9.1 Middle East and Africa
- 9.1.1 Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.1.1.1 Middle East and Africa Typhoid Fever Vaccines Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 South Africa:
Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 South Africa: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.1.2 South Africa: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.1.1.2 Saudi Arabia:
Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 Saudi Arabia: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.2.2 Saudi Arabia: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.1.1.3 UAE:
Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 UAE: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.3.2 UAE: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.1.1.4 Rest of Middle East and Africa:
Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Route of administration
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Middle East and Africa Typhoid Fever Vaccines Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 GlaxoSmithKline plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Shanghai institute of biological products co. ltd.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sanofi
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Pax Vax Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BHARAT BIOTECH
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For Middle East and Africa Typhoid Fever Vaccines Market
